|
|
|
European Pharmaceutical Contractor
|
CORDIA - *EuropaBio Convention 2003 is Europe's brand new life science convention. Launching in Vienna at the end of 2003, CORDIA is not simply a conference, nor is it purely an exhibition; its sole purpose is to provide a platform to stimulate the growth of the European biotechnology industry.
Life science research in Europe is world-class, and over the last few years a vigorous entrepreneurial industry has been born of existing long-standing strengths in the science base and techniques for the production of proteins and enzymes. This nascent SME-based biotech sector is beginning to deliver tangible societal and economic benefits in health care, agriculture and the environment.
Despite this the industry is fragmented across the enlarging European Community in terms of maturity, commercialisation, intellectual property implementation, product development and management expertise, available investment, societal acceptance and local national government support. There is therefore enormous opportunity but there is also a significant challenge for the European life science industry to deliver its contribution to the EC Lisbon 2000 Summit objective of Europe becoming the "foremost knowledge-based economy by 2010". CORDIA - EuropaBio Convention 2003 is being developed through an industry steering group to deliver both top-level thinking and practical advice on the issues that are impacting growth of the European life science sector on an international stage across five core streams and three core sectors of the industry as shown.
|
Read full article from PDF >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
Paediatric Clinical Trials
21-22 March 2012, Copthorne Tara Hotel, London, United Kingdom
Designing accurate and safe paediatric formulations is one of the topics being discussed at SMi’s Paediatric Clinical Trials held on 21st & 22nd March 2012
More info >> |
|
 |
News and Press Releases |
 |
Kallik’s new approach to asset management delivers long term artwork automisation
Marketing and compliance departments can now have greater control over their assets –from logos and images to labelling copy – and a roadmap to automated artwork generation, thanks to Kallik’s online Asset Repository. It is the most cost-effective way to lay the foundation for future automisation of the artwork and labelling generation. The practice of centralising the content in a web-based asset library and reusing those assets across all marketing and trade communications is saving businesses thousands, if not millions, of pounds.
More info >> |
|
|
